MICHAEL ROBERTS
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
HENRY AWMACK, MARK BAKNES, MARK E BAKNES, DAVID CAULFIELD, DAVID A. CAULFIELD, GEOFFREY CHATER, BIPIN GHELANI, ALAN HUTCHISON, GEORGE IRELAND, JOHN KANELLITAS, JOHN KANELLITSAS, CHRIS KERR, DOROTHY MILLER, JACK H. L. MILLER, ROSALIE MOORE, ADRIAN ROTHWELL, WILLIAM SCHUR, MARK SELBY, MARK T. SELBY, JASON WEBER
DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
JAMES ALT, MICHAEL APPEL, CHRISTOPHER BASHAM, BARBARA L. BURNS, JOHANN CLAPP, STEVEN E. DECILLIS, II, GREGORY DELANEY, MARTIN C. ELTRICH, III, ADAM GROMFIN, JAMES L. HO, JAN-ERIC KLOTH, KIRK MCLEAN, ALEXANDRE MEHFAR, JOLENE MYERS, JILL NORDQUIST, JON RAGAN, JONATHAN RYAN RAGAN, LAWRENCE TENEBAUM, DAVID UNTER, CARL WARSCHAUSKY, JESSIE WECHSLER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
DIRECTOR
TRAVIS BONNER, PETER D-ALESSANDRO, PETER ANGELO D-ALESSANDRO, JOE FRANKIE III, ROBERT GIBBS, EDWARD J GILLIARD, EDWARD J. GILLIARD, DAVID HATCHER, JR., CHRISTOPHER HORAN, WILLIAM MCCAUGHEY, RYAN QUINN, MICHAEL GABRIEL ROBERTS, TIMOTHY SMITH, TIMOTHY C. SMITH, JAMES TOLBERT, JEFFREY WHITE, CLIFFORD C. WRIGHT, JR.
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-12-22
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-12-22
D/A
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-12-22
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2025-12-22
D
OTHER
MINING, QUARRYING OF NONMETALLIC MINERALS (NO FUELS) [1400]
$1 - $1,000,000
Equity
2014-02-28

